Related content

Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin

By Mori Masaaki   Imagawa Tomoyuki   Katakura Shigeki   Miyamae Takako   Okuyama Ken-ichi   Ito Shuichi   Nakamura Tomoko   Kimura Hirokazu   Yokota Shumpei  

Modern Rheumatology, Vol. 14, Iss. 1, 2004-03 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Meta-analysis of the results of intravenous gamma globulin treatment of coronary artery lesions in Kawasaki disease

By Mori Masaaki   Miyamae Takako   Imagawa Tomoyuki   Katakura Shigeki   Kimura Kazuhiro   Yokota Shumpei  

Modern Rheumatology, Vol. 14, Iss. 5, 2004-11 ,pp. : 361-366

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 141-144

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of intravenous immunoglobulin‐resistant Kawasaki disease with methotrexate

By Ahn S   Kim D. S.  

Scandinavian Journal of Rheumatology, Vol. 34, Iss. 2, 2005-04 ,pp. : 136-139

Informa Healthcare

Access to resources Recommend Favorite

Circulating interleukin 17 is increased in the acute stage of Kawasaki disease

By Sohn MH   Noh SY   Chang W   Shin KM   Kim DS  

Scandinavian Journal of Rheumatology, Vol. 32, Iss. 6, 2003-11 ,pp. : 364-366

Informa Healthcare

Access to resources Recommend Favorite